American Gene Engineer Corp (1600784) SEC Filing 8-K Material Event for the period ending Wednesday, September 12, 2018

SEC Filings

1600784 Corporate News

  • Accountant Change
    Financial Exhibit

    September 2018

American Gene Engineer Corp

CIK: 1600784

View differences made from one to another to evaluate American Gene Engineer Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Gene Engineer Corp.


Assess how American Gene Engineer Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Gene Engineer Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

American Gene Engineer Corp provided additional information to their SEC Filing as exhibits

CIK: 1600784
Form Type: 8-K Corporate News
Accession Number: 0001214659-18-006028
Submitted to the SEC: Thu Sep 13 2018 4:41:29 PM EST
Accepted by the SEC: Thu Sep 13 2018
Period: Wednesday, September 12, 2018
Industry: Blank Checks
  1. Accountant Change
  2. Financial Exhibit

External Resources:

Bookmark the Permalink: